drug release – Page 2

Managing Non-Homogeneity in Dissolution Profiles for Coated Tablets

Managing Non-Homogeneity in Dissolution Profiles for Coated Tablets Managing Non-Homogeneity in Dissolution Profiles for Coated Tablets Introduction: Coated tablets are a widely used solid dosage form in the pharmaceutical industry,…

Addressing Deviations in Stability Studies for Bilayer Tablets

Addressing Deviations in Stability Studies for Bilayer Tablets Addressing Deviations in Stability Studies for Bilayer Tablets Introduction: Bilayer tablets have emerged as a versatile drug delivery system, offering the advantage…

Poor reproducibility in dissolution profiles for lipid-based capsules.

Poor reproducibility in dissolution profiles for lipid-based capsules. Poor reproducibility in dissolution profiles for lipid-based capsules. Introduction: Lipid-based capsules, encompassing both hard and soft gelatin varieties, are critical in the…

Problems with validating capsule release testing equipment.

Problems with validating capsule release testing equipment. Problems with Validating Capsule Release Testing Equipment Introduction: In the pharmaceutical industry, ensuring the consistent and reliable release of active pharmaceutical ingredients (APIs)…

Challenges in ensuring consistent capsule coating thickness during validation.

Challenges in ensuring consistent capsule coating thickness during validation. Challenges in ensuring consistent capsule coating thickness during validation. Introduction: In the pharmaceutical industry, capsules are a prevalent solid oral dosage…

Poor reproducibility in disintegration testing for coated capsules.

Poor reproducibility in disintegration testing for coated capsules. Poor reproducibility in disintegration testing for coated capsules Introduction: In the pharmaceutical industry, disintegration testing is a critical quality control measure that…

Difficulty in ensuring compliance with bioequivalence requirements for capsules.

Difficulty in ensuring compliance with bioequivalence requirements for capsules. Difficulty in ensuring compliance with bioequivalence requirements for capsules. Introduction: In the pharmaceutical industry, ensuring that generic formulations are bioequivalent to…

Inadequate methods for evaluating capsule dissolution in biorelevant media during stability studies.

Inadequate methods for evaluating capsule dissolution in biorelevant media during stability studies. Inadequate methods for evaluating capsule dissolution in biorelevant media during stability studies. Introduction: In the realm of pharmaceuticals,…

Identifying Problems in Potency Testing for Extended Release Tablets

Identifying Problems in Potency Testing for Extended Release Tablets Identifying Problems in Potency Testing for Extended Release Tablets Introduction: Extended release tablets are a cornerstone of modern pharmaceutical therapy, providing…

Addressing Coating Layer Delamination in Sustained Release Tablets

Addressing Coating Layer Delamination in Sustained Release Tablets Addressing Coating Layer Delamination in Sustained Release Tablets Introduction: The pharmaceutical industry continually seeks to enhance drug delivery systems, with sustained release…

Troubleshooting Thickness Testing Failures in Enteric-Coated Tablets

Troubleshooting Thickness Testing Failures in Enteric-Coated Tablets Troubleshooting Thickness Testing Failures in Enteric-Coated Tablets Introduction: Enteric-coated tablets are a critical component in the pharmaceutical industry, designed to deliver active ingredients…

Ensuring Adequate pH Stability in Enteric-Coated Tablets During Testing

Ensuring Adequate pH Stability in Enteric-Coated Tablets During Testing Ensuring Adequate pH Stability in Enteric-Coated Tablets During Testing Introduction: In the pharmaceutical industry, enteric-coated tablets play a crucial role in…